Literature DB >> 21740374

Applications of leukocyte- and platelet-rich plasma (L-PRP) in trauma surgery.

Ting Yuan1, Shang-Chun Guo, Pei Han, Chang-Qing Zhang, Bing-Fang Zeng.   

Abstract

Leukocyte- and platelet-rich plasma (L-PRP) contains high concentrations of platelet, leukocytes and other bioactivities, which play an prominent role in both bone and soft tissue healing processes. Large numbers of studies provide evidence for application of L-PRP in experiments and clinical practice. It has been identified to improve cellular chemotaxis, proliferation and differentiation, angiogenesis, and production of extracellular matrix, but also responsible for stimulating defense mechanisms against infections. L-PRP is now playing an increasing role in the management of patients with traumatic injuries. However, most studies are only anecdotal or case reports, and then larger controlled studies are needed. This article introduces the reader to L-PRP properties and L-PRP applications in trauma surgery, including applications of L-PRP in bone healing, acute soft tissue wound healing, and repairing of acute muscle, tendon, ligament, nerve and cartilage injury caused by trauma.

Entities:  

Mesh:

Year:  2012        PMID: 21740374     DOI: 10.2174/138920112800624445

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  26 in total

Review 1.  Augmenting tendon and ligament repair with platelet-rich plasma (PRP).

Authors:  Ting Yuan; Chang-Qing Zhang; James H-C Wang
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

Review 2.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

Review 3.  Platelet-Rich Plasma Promotes Axon Regeneration, Wound Healing, and Pain Reduction: Fact or Fiction.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2015-06-06       Impact factor: 5.590

4.  Role of Leukocyte-Platelet-Rich Fibrin in Endoscopic Endonasal Skull Base Surgery Defect Reconstruction.

Authors:  Liuba Soldatova; Raewyn G Campbell; Ahmad H Elkhatib; Thomas W Schmidt; Nelson R Pinto; Jaime M Pinto; Daniel M Prevedello; Leo F Ditzel Filho; Bradley A Otto; Ricardo L Carrau
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-28

5.  Chronic calcaneal osteomyelitis associated with soft-tissue defect could be successfully treated with platelet-rich plasma: a case report.

Authors:  Hsin-Fu Wang; You-Shui Gao; Ting Yuan; Xiao-Wei Yu; Chang-Qing Zhang
Journal:  Int Wound J       Date:  2012-02-24       Impact factor: 3.315

6.  Platelet-rich plasma promotes MSCs exosomes paracrine to repair acute kidney injury via AKT/Rab27 pathway.

Authors:  Cheng Ji; Jiahui Zhang; Zixuan Zhou; Hui Shi; Wanzhu Liu; Fengtian Sun; Chenxiao Zhang; Leilei Zhang; Zixuan Sun; Hui Qian
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 7.  Recommendations and considerations for the use of biologics in orthopedic surgery.

Authors:  Stefan Zwingenberger; Christophe Nich; Roberto D Valladares; Zhenyu Yao; Maik Stiehler; Stuart B Goodman
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

Review 8.  Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives.

Authors:  David M Dohan Ehrenfest; Isabel Andia; Matthias A Zumstein; Chang-Qing Zhang; Nelson R Pinto; Tomasz Bielecki
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

9.  Platelet-Rich Plasma-Derived Exosomal USP15 Promotes Cutaneous Wound Healing via Deubiquitinating EIF4A1.

Authors:  Yan Xu; Ze Lin; Lei He; Yanzhen Qu; Liu Ouyang; Yu Han; Chao Xu; Deyu Duan
Journal:  Oxid Med Cell Longev       Date:  2021-08-09       Impact factor: 6.543

Review 10.  Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries.

Authors:  Jie Fang; Xin Wang; Wen Jiang; Yaqiong Zhu; Yongqiang Hu; Yanxu Zhao; Xueli Song; Jinjuan Zhao; Wenlong Zhang; Jiang Peng; Yu Wang
Journal:  Tissue Eng Part B Rev       Date:  2020-11-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.